New eye drop aims to tame silent thief of sight
NCT ID NCT07354516
Summary
This study is testing a new, preservative-free eye drop called QLS-111-FDC to see if it safely lowers eye pressure in people with open-angle glaucoma or ocular hypertension. It will compare the new drop to a standard treatment (latanoprost) over 14 days. The main goal is to see how well it reduces pressure and how comfortable it feels to use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OAG - OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shettle Eye Research
RECRUITINGLargo, Florida, 33773, United States
Conditions
Explore the condition pages connected to this study.